Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPP Regulatory News (WPP)

Share Price Information for WPP (WPP)

Share Price is delayed by 15 minutes
Get Live Data
262.70    -8.60 (-3.17%)
Bid:
261.80
Ask:
264.70
Spread: 2.90 (1.108%)
Market Cap: £2.83b
WPP Live PriceLast checked at - London Stock Exchange

Intraday WPP Share Chart

Executive Performance Share Awards

14 Mar 2025 10:19

RNS Number : 7568A
WPP PLC
14 March 2025
Β 

FOR IMMEDIATE RELEASE 14 March 2025

Β 

WPP plc ("WPP")

Executive Performance Share Awards

Β 

On 12 March 2025, awards were made to the 2025 participants which comprise WPP's Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer as set out in the table below, and other select senior executives within the Group's operating companies.Β 

Executive Director

Number of shares awarded

Mark Read

714,432

Joanne Wilson

361,617

Andrew Scott

354,480

Β 

Awards take the form of nil-cost options or conditional awards of performance shares, which are exercisable over WPP shares or ADRs and the amounts stated represent the maximum possible opportunity.Β 

The extent to which awards become exercisable or vest in 2028 will depend on WPP's performance over the three-year performance period from 1 January 2025 to 31 December 2027.Β 

Awards are subject to three equally weighted performance measures: average Return on Invested Capital (ROIC), cumulative Adjusted Free Cash Flow (AFCF), and relative Total Shareholder Return (TSR). Achieving threshold performance will result in a vesting opportunity of 20% of the award. The vesting opportunity will increase on a straight-line basis to 100% of the award for maximum performance.Β 

Notes

1) These awards were made in accordance with the terms of the 2023 Directors' Compensation Policy as approved by shareholders on 17 May 2023

2) To the extent that each element of an award does not vest at the end of the three- year performance period it will lapse

3) Additional shares will be awarded at vesting in lieu of dividends on the shares that vest

4) Awards to Executive Directors are subject to an additional two-year post-vesting holding period

Β 

Β 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

NameΒ 

Mark Read

b)

Position/status

Chief Executive Officer

c)

Initial notification/amendment

Initial notification

2.

Details of the issuer

a)

Full name of the entity

WPP plc

b)

Legal Entity Identifier code

549300LSGBXPYHXGDT93

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 10 pence each ('Ordinary Shares')

ISIN: JE00B8KF9B49

b)

Nature of the transaction

Grant of award over WPP plc ordinary shares under the WPP plc Executive Performance Share Plan

c)

Price(s) and volume(s) (Number of WPP ordinary shares or WPP ADRs sold or purchased and price per share/ADR)

Price(s)

Volume(s)

Nil cost option

714,432

d)

Aggregated information

- Aggregated number

- Aggregated Price

- Total

N/A (single transaction)

Β 

e)

Date of the transaction

12 March 2025

f)

Place of the transaction

London Stock Exchange (XLON)

Β 

Β 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

NameΒ 

Joanne Wilson

b)

Position/status

Chief Financial Officer

c)

Initial notification/amendment

Initial notification

2.

Details of the issuer

a)

Full name of the entity

WPP plc

b)

Legal Entity Identifier code

549300LSGBXPYHXGDT93

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 10 pence each ('Ordinary Shares')

ISIN: JE00B8KF9B49

b)

Nature of the transaction

Grant of award over WPP plc ordinary shares under the WPP plc Executive Performance Share Plan

c)

Price(s) and volume(s) (Number of WPP ordinary shares or WPP ADRs sold or purchased and price per share/ADR)

Price(s)

Volume(s)

Nil cost option

361,617

d)

Aggregated information

- Aggregated number

- Aggregated Price

- Total

N/A (single transaction)

Β 

e)

Date of the transaction

12 March 2025

f)

Place of the transaction

London Stock Exchange (XLON)

Β 

Β 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

NameΒ 

Andrew Scott

b)

Position/status

Chief Operating Officer

c)

Initial notification/amendment

Initial notification

2.

Details of the issuer

a)

Full name of the entity

WPP plc

b)

Legal Entity Identifier code

549300LSGBXPYHXGDT93

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 10 pence each ('Ordinary Shares')

ISIN: JE00B8KF9B49

b)

Nature of the transaction

Grant of award over WPP plc ordinary shares under the WPP plc Executive Performance Share Plan

c)

Price(s) and volume(s) (Number of WPP ordinary shares or WPP ADRs sold or purchased and price per share/ADR)

Price(s)

Volume(s)

Nil cost option

354,480

d)

Aggregated information

- Aggregated number

- Aggregated Price

- Total

N/A (single transaction)

Β 

e)

Date of the transaction

12 March 2025

f)

Place of the transaction

London Stock Exchange (XLON)

Β 

This notice is given in fulfilment of the obligation under Article 19 of the Market Abuse Regulation.

Balbir Kelly-Bisla

Group Company Secretary

Β 

Further informationΒ 

Media:Β press@wpp.com

Investors:Β irteam@wpp.com

Β 

About WPP

WPP is the creative transformation company. We use the power of creativity to build better futures for our people, planet clients and communities. For more information, visitΒ www.wpp.com.

Β 

END

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHUSARRVBUOAAR
Date   Source Headline
7th Sep 20232:49 pmRNSBoard Change
1st Sep 20239:57 amRNSTotal Voting Rights and Capital
7th Aug 20233:01 pmRNSDirector / PDMR Transaction notification
4th Aug 20237:00 amRNS2023 Interim Results
1st Aug 20234:18 pmRNSTotal Voting Rights and Capital
11th Jul 202312:36 pmRNSNotification of Interim Results
3rd Jul 202311:50 amRNSTotal Voting Rights and Capital
20th Jun 20231:00 pmRNSAcquisition
1st Jun 202310:48 amRNSTotal Voting Rights and Capital
17th May 20232:46 pmRNSResults of AGM
16th May 202312:00 pmRNSVesting of executive share award
9th May 20234:15 pmRNSExecutive Share Awards
2nd May 202311:11 amRNSTotal Voting Rights and Capital
27th Apr 20237:00 amRNSFirst Quarter Trading Update
20th Apr 202311:00 amRNSAcquisition
11th Apr 202310:30 amRNSUpdate re FGS Global
3rd Apr 202312:50 pmRNSTotal Voting Rights and Capital
28th Mar 202310:40 amRNSNotification of Trading Update
27th Mar 20233:00 pmRNSAcquisition
27th Mar 20232:41 pmRNSExecutive Performance Share Awards
24th Mar 20237:00 amRNSAnnual Report 2022 on Form 20-F
23rd Mar 20234:21 pmRNSAnnual Report 2022 and AGM Notice
23rd Mar 202311:15 amRNSBoard Change
22nd Mar 202312:46 pmRNSCFO Transition Update
22nd Mar 20237:00 amRNSAcquisition
17th Mar 202310:54 amRNSVesting of Executive Share Award
15th Mar 20232:44 pmRNSBoard and Committee membership changes
7th Mar 20237:00 amRNSAcquisition
1st Mar 20232:07 pmRNSTotal Voting Rights and Capital
27th Feb 202310:45 amRNSDirector / PDMR Transaction notification
23rd Feb 20237:00 amRNS2022 Preliminary Results
1st Feb 20231:04 pmRNSTotal Voting Rights and Capital
19th Jan 20233:47 pmRNSNotification of 2022 Preliminary Results
5th Jan 20232:00 pmRNSAcquisition
3rd Jan 20231:26 pmRNSTotal Voting Rights and Capital
8th Dec 202212:00 pmRNSAcquisition
1st Dec 20223:53 pmRNSTotal Voting Rights and Capital
24th Nov 20227:00 amRNSTransaction in Own Shares
23rd Nov 20227:00 amRNSTransaction in Own Shares
22nd Nov 20227:00 amRNSTransaction in Own Shares
21st Nov 20227:00 amRNSTransaction in Own Shares
18th Nov 20227:00 amRNSTransaction in Own Shares
17th Nov 20227:00 amRNSTransaction in Own Shares
16th Nov 20227:00 amRNSTransaction in Own Shares
15th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20227:00 amRNSTransaction in Own Shares
11th Nov 20227:00 amRNSTransaction in Own Shares
10th Nov 20227:00 amRNSTransaction in Own Shares
9th Nov 20227:00 amRNSTransaction in Own Shares
8th Nov 20227:00 amRNSWPP ANNOUNCES CFO TRANSITION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.